GlassScriptPhysician profile
Joshua Bowman
NPI 1477817179
$379.79
in general payments reported to CMS, 2019-2025
10 companies · $60.90 in 2025
The $60.90 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.06 · 2020: $26.89 · 2021: $142 · 2022: $22.52 · 2023: $54.12 · 2024: $33.97 · 2025: $60.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $148.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $99.94 | 2021 | |
| Amgen INC. | $58.53 | 2024-2025 | Krystexxa |
| Smith+Nephew, INC. | $56.89 | 2023-2025 | Collagenase Santyl, Renasys Touch |
| Orthofix Medical, INC. | $33.57 | 2023 | Cervical-Stim, Physio-Stim |
| Wright Medical Technology, INC. | $32.51 | 2019-2020 | |
| Novo Nordisk INC | $32.18 | 2020-2021 | |
| Horizon Therapeutics Plc | $22.52 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.30 | 2019 | |
| Abbott Laboratories | $13.06 | 2021 | |
| Merck Sharp & Dohme LLC | $12.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Bowman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.